Neovasc Inc (US) Stock Price, News & Analysis (NASDAQ:NVCN)

$0.23 -0.01 (-4.17 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$0.23
Today's Range$0.22 - $0.25
52-Week Range$0.22 - $2.12
Volume4.87 million shs
Average Volume2.57 million shs
Market Capitalization$23.85 million
P/E Ratio0.85
Dividend YieldN/A
Beta1.23

About Neovasc Inc (US) (NASDAQ:NVCN)

Neovasc Inc (US) logoNeovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.

Receive NVCN News and Ratings via Email

Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:NVCN
CUSIPN/A
Phone+1-604-2704344

Debt

Debt-to-Equity RatioN/A
Current Ratio0.69%
Quick Ratio0.69%

Price-To-Earnings

Trailing P/E Ratio0.851851851851852
Forward P/E Ratio-1.10
P/E GrowthN/A

Sales & Book Value

Annual Sales$9.51 million
Price / Sales1.91
Cash Flow$0.10 per share
Price / Cash2.36
Book Value($0.20) per share
Price / Book-1.15

Profitability

Trailing EPS$0.27
Net Income$-86,490,000.00
Net Margins268.35%
Return on Equity-85.81%
Return on Assets23.39%

Miscellaneous

Employees147
Outstanding Shares78,920,000

Neovasc Inc (US) (NASDAQ:NVCN) Frequently Asked Questions

What is Neovasc Inc (US)'s stock symbol?

Neovasc Inc (US) trades on the NASDAQ under the ticker symbol "NVCN."

How were Neovasc Inc (US)'s earnings last quarter?

Neovasc Inc (US) (NASDAQ:NVCN) issued its quarterly earnings data on Tuesday, March, 29th. The medical equipment provider reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.04. The medical equipment provider had revenue of $2.24 million for the quarter, compared to analysts' expectations of $3.26 million. Neovasc Inc (US) had a negative return on equity of 85.81% and a net margin of 268.35%. View Neovasc Inc (US)'s Earnings History.

When will Neovasc Inc (US) make its next earnings announcement?

Neovasc Inc (US) is scheduled to release their next quarterly earnings announcement on Thursday, March, 22nd 2018. View Earnings Estimates for Neovasc Inc (US).

Where is Neovasc Inc (US)'s stock going? Where will Neovasc Inc (US)'s stock price be in 2018?

4 equities research analysts have issued 1 year price objectives for Neovasc Inc (US)'s shares. Their forecasts range from $1.05 to $5.00. On average, they expect Neovasc Inc (US)'s stock price to reach $3.35 in the next twelve months. View Analyst Ratings for Neovasc Inc (US).

Are investors shorting Neovasc Inc (US)?

Neovasc Inc (US) saw a decline in short interest in the month of January. As of January 31st, there was short interest totalling 1,186,659 shares, a decline of 56.6% from the January 12th total of 2,731,352 shares. Based on an average trading volume of 1,625,365 shares, the days-to-cover ratio is currently 0.7 days. Currently, 3.5% of the company's shares are sold short.

Who are some of Neovasc Inc (US)'s key competitors?

Who are Neovasc Inc (US)'s key executives?

Neovasc Inc (US)'s management team includes the folowing people:

  • Paul L. Geyer, Independent Chairman of the Board
  • Fred Colen, President, Chief Executive Officer
  • Christopher Clark, Chief Financial Officer, Corporate Secretary
  • Brian McPherson, Chief Operating Officer
  • Vicki Lee Bebeau, Vice President - Clinical Affairs
  • Randy Lane, Vice President - Research & Development
  • Alexei J. Marko, Director
  • Jane H. Hsiao Ph.D., Independent Director (Age 69)
  • Douglas Glen Janzen, Independent Director
  • William O'Neill, Independent Director (Age 61)

Who owns Neovasc Inc (US) stock?

Neovasc Inc (US)'s stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Hudson Bay Capital Management LP (13.12%), Gagnon Advisors LLC (2.32%) and Bailard Inc. (0.42%). View Institutional Ownership Trends for Neovasc Inc (US).

Who sold Neovasc Inc (US) stock? Who is selling Neovasc Inc (US) stock?

Neovasc Inc (US)'s stock was sold by a variety of institutional investors in the last quarter, including Bailard Inc.. View Insider Buying and Selling for Neovasc Inc (US).

Who bought Neovasc Inc (US) stock? Who is buying Neovasc Inc (US) stock?

Neovasc Inc (US)'s stock was bought by a variety of institutional investors in the last quarter, including Hudson Bay Capital Management LP and Gagnon Advisors LLC. View Insider Buying and Selling for Neovasc Inc (US).

How do I buy Neovasc Inc (US) stock?

Shares of Neovasc Inc (US) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neovasc Inc (US)'s stock price today?

One share of Neovasc Inc (US) stock can currently be purchased for approximately $0.23.

How big of a company is Neovasc Inc (US)?

Neovasc Inc (US) has a market capitalization of $23.85 million and generates $9.51 million in revenue each year. The medical equipment provider earns $-86,490,000.00 in net income (profit) each year or $0.27 on an earnings per share basis. Neovasc Inc (US) employs 147 workers across the globe.

How can I contact Neovasc Inc (US)?

Neovasc Inc (US)'s mailing address is 13562 Maycrest Way Suite 5138, RICHMOND, BC V6V 2J7, Canada. The medical equipment provider can be reached via phone at +1-604-2704344 or via email at [email protected]


MarketBeat Community Rating for Neovasc Inc (US) (NVCN)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  159 (Vote Outperform)
Underperform Votes:  141 (Vote Underperform)
Total Votes:  300
MarketBeat's community ratings are surveys of what our community members think about Neovasc Inc (US) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Neovasc Inc (US) (NASDAQ:NVCN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.35$3.35$6.33$6.33
Price Target Upside: 544.23% upside544.23% upside313.94% upside313.94% upside

Neovasc Inc (US) (NASDAQ:NVCN) Consensus Price Target History

Price Target History for Neovasc Inc (US) (NASDAQ:NVCN)

Neovasc Inc (US) (NASDAQ:NVCN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/19/2018Canaccord GenuityReiterated RatingBuy -> Buy$1.05HighView Rating Details
4/5/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$4.00HighView Rating Details
4/3/2017JMP SecuritiesReiterated RatingOutperform$5.00MediumView Rating Details
3/23/2017Leerink SwannReiterated RatingOutperformHighView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Neovasc Inc (US) (NASDAQ:NVCN) Earnings History and Estimates Chart

Earnings by Quarter for Neovasc Inc (US) (NASDAQ:NVCN)

Neovasc Inc (US) (NASDAQ NVCN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/22/2018        
11/14/2017Q3 2017($0.02)($0.06)$1.42 million$1.38 millionViewN/AView Earnings Details
8/10/20176/30/2017($0.02)($0.04)$1.40 million$1.31 millionViewN/AView Earnings Details
5/10/2017Q1 2017($0.08)($0.10)$3.90 million$1.48 millionViewN/AView Earnings Details
3/23/2017Q4 2016$0.47$3.00 million$2.76 millionViewN/AView Earnings Details
11/14/2016Q216($0.06)($0.12)$2.20 million$3.03 millionViewN/AView Earnings Details
8/9/2016Q2 2016($0.09)($0.20)$3.20 million$1.71 millionViewN/AView Earnings Details
4/29/2016Q1 2016($0.10)($0.10)$3.10 million$2.01 millionViewN/AView Earnings Details
3/29/2016Q415($0.15)($0.11)$3.26 million$2.24 millionViewN/AView Earnings Details
11/9/2015Q3 2015($0.10)($0.11)$3.46 million$2.48 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.10)($0.10)$3.19 million$2.93 millionViewN/AView Earnings Details
5/12/2015Q115($0.05)($0.08)$3.84 million$2.86 millionViewN/AView Earnings Details
3/30/2015Q414($0.06)($0.11)$3.31 million$3.35 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.08)$3.77 millionViewN/AView Earnings Details
8/13/2014Q2 2014($0.11)$4.03 millionViewN/AView Earnings Details
5/22/2014Q1 2014($0.01)$3.48 millionViewN/AView Earnings Details
4/17/2014Q4 2013($0.04)$3.22 millionViewN/AView Earnings Details
11/20/2013Q3 2013($0.03)$3.50 millionViewN/AView Earnings Details
8/15/2013Q2 2013($0.03)$2.73 millionViewN/AView Earnings Details
5/28/2013Q1 2013($0.04)$2.00 millionViewN/AView Earnings Details
4/29/2013Q4 2012($0.02)ViewN/AView Earnings Details
11/26/2012Q3 2012($0.03)ViewN/AView Earnings Details
8/9/2012Q2 2012($0.03)ViewN/AView Earnings Details
5/29/2012Q1 2012($0.03)ViewN/AView Earnings Details
4/25/2012Q4 2011($0.02)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Neovasc Inc (US) (NASDAQ:NVCN) Earnings Estimates

2018 EPS Consensus Estimate: $0.00
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.00$0.00$0.00
Q2 20181$0.00$0.00$0.00
Q3 20181$0.00$0.00$0.00
Q4 20181$0.00$0.00$0.00
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Neovasc Inc (US) (NASDAQ:NVCN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neovasc Inc (US) (NASDAQ NVCN)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Neovasc Inc (US) (NASDAQ NVCN) News Headlines

Source:
DateHeadline
Neovasc Inc (US) (NVCN) Given Average Rating of "Hold" by AnalystsNeovasc Inc (US) (NVCN) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - February 13 at 9:22 AM
Neovasc to Present at LEERINK Partners 7th Annual Global Healthcare ConferenceNeovasc to Present at LEERINK Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 12 at 3:21 PM
Short Interest in Neovasc Inc (US) (NVCN) Drops By 56.6%Short Interest in Neovasc Inc (US) (NVCN) Drops By 56.6%
www.americanbankingnews.com - February 11 at 1:32 AM
Neovascs Reducer nabs elevated reimbursement status in ... - Seeking AlphaNeovasc's Reducer nabs elevated reimbursement status in ... - Seeking Alpha
seekingalpha.com - February 1 at 3:20 PM
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory AnginaNeovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina
finance.yahoo.com - February 1 at 3:20 PM
Neovasc Inc (US) (NVCN) and Cerner (CERN) Financial ContrastNeovasc Inc (US) (NVCN) and Cerner (CERN) Financial Contrast
www.americanbankingnews.com - January 31 at 11:16 AM
Neovasc Inc (US) (NVCN) Stock Rating Lowered by Zacks Investment ResearchNeovasc Inc (US) (NVCN) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - January 31 at 6:16 AM
Neovasc (NVCN) Names Fred Colen as CEO - StreetInsider.comNeovasc (NVCN) Names Fred Colen as CEO - StreetInsider.com
www.streetinsider.com - January 22 at 3:25 PM
Fred Colen Appointed Chief Executive Officer of Neovasc Inc.Fred Colen Appointed Chief Executive Officer of Neovasc Inc.
finance.yahoo.com - January 22 at 8:29 AM
Canaccord Genuity Initiates Coverage on Neovasc Inc (US) (NVCN)Canaccord Genuity Initiates Coverage on Neovasc Inc (US) (NVCN)
www.americanbankingnews.com - January 20 at 6:18 PM
Neovasc Inc (US) (NVCN) Receives Average Recommendation of "Buy" from BrokeragesNeovasc Inc (US) (NVCN) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - January 19 at 10:32 AM
Neovasc Reducer Featured in Live Case at Berlin SymposiumNeovasc Reducer Featured in Live Case at Berlin Symposium
finance.yahoo.com - January 18 at 11:18 AM
Neovasc Reports Tiaras Clinical Case Load AcceleratingNeovasc Reports Tiara's Clinical Case Load Accelerating
finance.yahoo.com - January 8 at 10:30 AM
Neovasc Receives NASDAQ Notification Regarding Minimum Bid RequirementsNeovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements
finance.yahoo.com - January 2 at 5:23 PM
Neovasc Inc (US) (NVCN) Rating Lowered to Strong Sell at ValuEngineNeovasc Inc (US) (NVCN) Rating Lowered to Strong Sell at ValuEngine
www.americanbankingnews.com - January 1 at 3:10 PM
Luminex (LMNX) and Neovasc Inc (US) (NVCN) Head-To-Head ReviewLuminex (LMNX) and Neovasc Inc (US) (NVCN) Head-To-Head Review
www.americanbankingnews.com - December 20 at 7:10 PM
Critical Analysis: Neovasc Inc (US) (NVCN) and The CompetitionCritical Analysis: Neovasc Inc (US) (NVCN) and The Competition
www.americanbankingnews.com - December 20 at 11:28 AM
Head to Head Analysis: Neovasc Inc (US) (NVCN) & Its RivalsHead to Head Analysis: Neovasc Inc (US) (NVCN) & Its Rivals
www.americanbankingnews.com - December 19 at 5:24 PM
Financial Review: Neovasc Inc (US) (NVCN) vs. Its CompetitorsFinancial Review: Neovasc Inc (US) (NVCN) vs. Its Competitors
www.americanbankingnews.com - December 19 at 7:10 AM
Head to Head Contrast: Neovasc Inc (US) (NVCN) & Its CompetitorsHead to Head Contrast: Neovasc Inc (US) (NVCN) & Its Competitors
www.americanbankingnews.com - December 10 at 3:26 AM
Head-To-Head Survey: Neovasc Inc (US) (NVCN) and The CompetitionHead-To-Head Survey: Neovasc Inc (US) (NVCN) and The Competition
www.americanbankingnews.com - December 8 at 3:26 AM
Neovasc Reducer Featured in Live Case at ICI 2017Neovasc Reducer Featured in Live Case at ICI 2017
finance.yahoo.com - December 6 at 10:38 AM
Pre-market Technical Scan on Medical Equipment Equities ... - PR Newswire (press release)Pre-market Technical Scan on Medical Equipment Equities ... - PR Newswire (press release)
www.prnewswire.com - December 5 at 4:31 PM
Neovasc (NVCN) Cut to Strong Sell at ValuEngineNeovasc (NVCN) Cut to Strong Sell at ValuEngine
www.americanbankingnews.com - December 2 at 11:22 PM
Neovasc, Inc. :NVCN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Neovasc, Inc. :NVCN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 10:28 AM
Neovasc Inc. (NVCN) Short Interest Up 87.3% in NovemberNeovasc Inc. (NVCN) Short Interest Up 87.3% in November
www.americanbankingnews.com - November 29 at 1:34 AM
Head-To-Head Analysis: Neovasc (NVCN) and Its RivalsHead-To-Head Analysis: Neovasc (NVCN) and Its Rivals
www.americanbankingnews.com - November 25 at 3:20 PM
Neovasc (NVCN) and Its Competitors Critical SurveyNeovasc (NVCN) and Its Competitors Critical Survey
www.americanbankingnews.com - November 21 at 11:49 AM
Neovasc reports 3Q lossNeovasc reports 3Q loss
finance.yahoo.com - November 18 at 9:25 AM
At $0.99, Is Neovasc Inc (TSX:NVCN) A Buy?At $0.99, Is Neovasc Inc (TSX:NVCN) A Buy?
finance.yahoo.com - November 18 at 9:25 AM
Neovasc Closes Offering of Units Consisting of Common Shares and Warrants and Concurrent Private Placement of Notes and WarrantsNeovasc Closes Offering of Units Consisting of Common Shares and Warrants and Concurrent Private Placement of Notes and Warrants
finance.yahoo.com - November 18 at 9:25 AM
Neovasc Inc. (NVCN) Forecasted to Post FY2017 Earnings of ($0.19) Per ShareNeovasc Inc. (NVCN) Forecasted to Post FY2017 Earnings of ($0.19) Per Share
www.americanbankingnews.com - November 17 at 8:30 PM
Neovasc: When Management Is Fraudulent, You Are Toast ... - Seeking AlphaNeovasc: When Management Is Fraudulent, You Are Toast ... - Seeking Alpha
seekingalpha.com - November 15 at 6:57 AM
Neovasc Announces Results for the Third Quarter of 2017Neovasc Announces Results for the Third Quarter of 2017
finance.yahoo.com - November 15 at 6:57 AM
Neovasc Inc. (NVCN) Set to Announce Quarterly Earnings on TuesdayNeovasc Inc. (NVCN) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - November 13 at 8:54 AM
Neovasc (NVCN) Prices 6.609M Series A Unit and 19.07M Series B Unit Common Share/Warrant Offering at $1.46/UnitNeovasc (NVCN) Prices 6.609M Series A Unit and 19.07M Series B Unit Common Share/Warrant Offering at $1.46/Unit
www.streetinsider.com - November 12 at 11:09 AM
Neovasc Announces US$65 Million Underwritten Offering of Units Consisting of Common Shares and Warrants To Purchase Common Shares and Concurrent Private Placement of Notes and WarrantsNeovasc Announces US$65 Million Underwritten Offering of Units Consisting of Common Shares and Warrants To Purchase Common Shares and Concurrent Private Placement of Notes and Warrants
finance.yahoo.com - November 12 at 11:08 AM
Neovasc to Host Third Quarter 2017 Conference CallNeovasc to Host Third Quarter 2017 Conference Call
finance.yahoo.com - November 12 at 11:08 AM
Neovasc (NVCN) Granted FDA Approval to Initiate Pivotal Reducer ... - StreetInsider.comNeovasc (NVCN) Granted FDA Approval to Initiate Pivotal Reducer ... - StreetInsider.com
www.streetinsider.com - November 7 at 7:55 AM
Neovasc Receives FDA Approval to Initiate Pivotal Reducer TrialNeovasc Receives FDA Approval to Initiate Pivotal Reducer Trial
finance.yahoo.com - November 7 at 7:55 AM
Comparing Quidel Corporation (QDEL) & Neovasc (NVCN)Comparing Quidel Corporation (QDEL) & Neovasc (NVCN)
www.americanbankingnews.com - November 6 at 7:24 AM
Neovasc Inc. - StreetInsider.comNeovasc Inc. - StreetInsider.com
www.streetinsider.com - November 4 at 8:15 AM
What You Must Know About Neovasc Inc’s (TSX:NVCN) Major InvestorsWhat You Must Know About Neovasc Inc’s (TSX:NVCN) Major Investors
finance.yahoo.com - November 4 at 8:15 AM
Neovasc Provides Litigation UpdateNeovasc Provides Litigation Update
finance.yahoo.com - November 4 at 8:15 AM
Contrasting Presbia PLC (LENS) & Neovasc (NVCN)Contrasting Presbia PLC (LENS) & Neovasc (NVCN)
www.americanbankingnews.com - October 17 at 10:24 PM
Neovasc Inc. (NVCN) Stock Rating Upgraded by Zacks Investment ResearchNeovasc Inc. (NVCN) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - October 16 at 12:14 AM
Neovasc Inc. (NVCN) Sees Large Drop in Short InterestNeovasc Inc. (NVCN) Sees Large Drop in Short Interest
www.americanbankingnews.com - October 14 at 1:40 AM
Contrasting Neovasc (NVCN) and Koninklijke Philips N.V. (PHG)Contrasting Neovasc (NVCN) and Koninklijke Philips N.V. (PHG)
www.americanbankingnews.com - October 7 at 8:38 AM
Dilution Ahead For Neovasc Inc (TSX:NVCN) Shareholders?Dilution Ahead For Neovasc Inc (TSX:NVCN) Shareholders?
finance.yahoo.com - October 5 at 12:48 PM
Why You Need To Look At This Factor Before Buying Neovasc Inc (TSX:NVCN)Why You Need To Look At This Factor Before Buying Neovasc Inc (TSX:NVCN)
finance.yahoo.com - September 16 at 7:11 AM

SEC Filings

Neovasc Inc (US) (NASDAQ:NVCN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Neovasc Inc (US) (NASDAQ:NVCN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Neovasc Inc (US) (NASDAQ NVCN) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.